Auna reports Q3 adjusted EBITDA PEN231M, down 7% y/y

Reports Q3 revenue PEN1.12B, down 1% y/y. The company states: “Despite weaker financial yet promising operational results, the third quarter of 2025 demonstrates the enduring resilience of Auna‘s (AUNA) integrated regional healthcare platform and the robust performance of our operations. The operations in Peru and Colombia achieved substantial growth and profitability in local currency, despite challenging macroeconomic conditions, while in our Mexico business, which is slowly recovering from previously communicated challenges, hospital operations remained stable, although the segment delivered less favorable financial results. In Peru, both Oncosalud and Healthcare Services delivered consistently strong performance levels, supported by growth in memberships, annual pricing adjustments, and the sustained improvement of the Oncology MLR to 49.3%. The disciplined containment of costs and the operational efficiency of our medical talent continued to underpin this performance.”